ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
MONDAY, April 8, 2024 -- Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Angioplasty | Aspirin | Bleeding | Coronary Angioplasty | Percutaneous Coronary Intervention | Pharmaceuticals